A detailed history of Bryn Mawr Trust CO transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Bryn Mawr Trust CO holds 764 shares of PRCT stock, worth $54,435. This represents 0.0% of its overall portfolio holdings.

Number of Shares
764
Previous 794 3.78%
Holding current value
$54,435
Previous $63,000 3.17%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 28, 2025

SELL
$67.27 - $99.45 $2,018 - $2,983
-30 Reduced 3.78%
764 $61,000
Q3 2024

Nov 25, 2024

BUY
$56.31 - $84.99 $44,710 - $67,482
794 New
794 $63,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $3.18B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Bryn Mawr Trust CO Portfolio

Follow Bryn Mawr Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.